FDA Inspection 917536 — B. Braun US Pharmaceutical Manufacturing, LLC

B. Braun US Pharmaceutical Manufacturing, LLC — FEI 2021236

The FDA completed an inspection of B. Braun US Pharmaceutical Manufacturing, LLC on March 3, 2015 in Irvine, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 3, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Irvine, CA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
194221 CFR 211.180(e)Records reviewed annually
202721 CFR 211.192Investigations of discrepancies, failures
241921 CFR 211.198(a)Complaint Handling Procedure
890721 CFR 314.81(b)(1)(ii)Contamination, chemical or physical change, deterioration